HMI-102

GENETIC2 trials

Sponsors

Homology Medicines, Inc

Conditions

PAH DeficiencyPhenylketonuriaPhenylketonurias

Phase 1

Gene Therapy Clinical Study in Adult PKU

TerminatedNCT03952156

Homology Medicines, IncPAH Deficiency, Phenylketonurias

Start: 2019-06-10End: 2023-08-01Updated: 2023-08-29

Unknown Phase

Long-Term Follow Up Study of Subjects Previously Administered HMI 102

Enrolling by invitationNCT04348708

Homology Medicines, IncPAH Deficiency, Phenylketonuria

Start: 2020-08-19End: 2026-12-01Target: 21Updated: 2022-06-30